Scientists and clinicians at TRI are working towards improved diagnosis and treatment of various cancers including breast, prostate, head and neck, and skin cancers.

In 2018, an estimated 140,000 new cases of cancer were diagnosed, and just under 50,000 people died from the disease (AIHW, 2018). In Australia, the most commonly diagnosed cancers are currently breast cancer, followed by prostate cancer, colorectal cancer and melanoma.(AIHW, 2018

Researchers at TRI are working closely with clinicians to identify novel ways to detect, diagnose, monitor and treat various types of cancers. These projects include specialist cancer groups across QUT's Institute of Health and Biomedical Innovation, Mater Research, The University of Queensland.

Image: Cancer tumour spheroid with fluorescent labelling according to cell phenotype. Crystal Tonnessen (June 2015).

Key Researchers
Andrew Perkins
Nicholas Andrew Saunders
Colleen Nelson
Geoffrey Faulkner
Ingrid Winkler
Jean-Pierre Levesque
John Hooper
Judith Clements
Kristen Radford
Maher Gandhi
Show More ...
Click a program below to learn more
Blood Cancer
Breast Cancer
Cervical Cancer
Head and Neck Cancer
Kidney Cancer
Lung Cancer
Ovarian Cancer
Prostate Cancer
Skin Cancer
Interview with Prof John Hooper about pancreatic cancer research
Hodgkin's lymphoma breakthrough leads to better treatment Queensland research into Hodgkin’s lymphoma has discovered a way to help individualise cancer treatment for each patient, with...Read more
QIMR BERGHOFER Student seminar Damien Gardiner, Cancer Drug Mechanism Group, QIMR Berghofer Perineural spread of cutaneous malignancy in a live mouse and ganglion tumour co-culture model Richard Lobb...Read more
APCRC-Q leads a Revolutionary team award The Australian Prostate Cancer Research Centre - Queensland (APCRC-Q) is leading a team of 39 investigators that have been awarded one of Australia’s...Read more
Eco-oncology: implementing principles of ecology into oncology A/Prof Reynolds studies aggressive paediatric and adult brain cancer and is developing novel translational approaches to combat this...Read more